맞춤형 의료 바이오마커 시장 보고서(2026년)

Personalized medicine biomarkers are distinct biological indicators used to customize medical treatments for individual patients according to their unique genetic, molecular, or physiological traits. These biomarkers can assist in predicting a patient's response to a specific drug, allowing doctors to select the most effective and safest treatment options.

The primary types of biomarkers in personalized medicine include genomic, proteomic, metabolic, and others. Genomic biomarkers are specific genes or genetic mutations that assist in understanding how diseases develop and progress in individuals. They are utilized for a range of disease indications, such as oncology, neurology, diabetes, autoimmune disorders, cardiology, and more, for various purposes including early detection or screening, diagnosis, treatment selection, and monitoring. They serve a variety of end users, including hospitals and clinics, pharmaceutical and biotechnology companies, diagnostic laboratories, and others.

Tariffs have affected the personalized medicine biomarkers market by increasing the cost of imported reagents, sequencing consumables, assay kits, and analytical components used in biomarker development and testing. These impacts have been most pronounced in genomic and proteomic biomarker segments, particularly in north america and europe where laboratory supply chains are globally diversified. Asia-pacific manufacturers have faced pricing pressure due to dependency on imported diagnostic inputs. However, tariffs have encouraged regional production of biomarker kits and localized manufacturing, supporting supply resilience and long-term cost optimization.

The personalized medicine biomarkers market research report is one of a series of new reports from The Business Research Company that provides personalized medicine biomarkers market statistics, including personalized medicine biomarkers industry global market size, regional shares, competitors with a personalized medicine biomarkers market share, detailed personalized medicine biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine biomarkers industry. This personalized medicine biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized medicine biomarkers market size has grown rapidly in recent years. It will grow from $26.73 billion in 2025 to $31.34 billion in 2026 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to advances in genomic research, rising cancer incidence, growth of targeted therapies, increased use of molecular diagnostics, regulatory support for precision medicine.

The personalized medicine biomarkers market size is expected to see rapid growth in the next few years. It will grow to $58.8 billion in 2030 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to expansion of personalized therapeutics, rising demand for early disease detection, growth in pharmacogenomics, increasing investment in biomarker discovery, wider adoption across non-oncology indications. Major trends in the forecast period include rising adoption of precision treatment approaches, increasing use of biomarkers in oncology care, growing integration of companion diagnostics, expansion of predictive and prognostic biomarkers, higher focus on treatment response monitoring.

The increasing prevalence of chronic diseases is expected to drive the growth of the personalized medicine biomarkers market in the coming years. Chronic diseases are long-lasting medical conditions that develop gradually and persist for a year or longer, requiring continuous medical care or limiting everyday activities. The rise in chronic diseases is attributed to unhealthy lifestyle habits, poor diets, insufficient physical activity, and elevated stress levels. Personalized medicine biomarkers assist in customizing treatments for chronic diseases by identifying effective therapies, forecasting disease progression, and reducing adverse effects based on individual genetic and molecular profiles. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based health authority, reported that by 2050, the number of new cancer cases is projected to exceed 35 million, marking a 77% increase from the estimated 20 million cases in 2022. Hence, the rising prevalence of chronic diseases is fueling the growth of the personalized medicine biomarkers market.

Major companies operating in the personalized medicine biomarkers market are concentrating on securing regulatory approvals, such as companion diagnostic approval, to improve precision oncology by quickly matching patients with targeted therapies. Companion diagnostic approval is the regulatory authorization granted by a health authority (such as the FDA) for a diagnostic test specifically designed to identify patients most likely to benefit from a particular therapeutic product or who may face an increased risk of adverse reactions. For example, in August 2024, Illumina, Inc., a US-based biotechnology company, received Food and Drug Administration (FDA) approval for its cancer biomarker test along with two companion diagnostics. The test employs next-generation sequencing (NGS) technology to detect genetic mutations in cancer cells, allowing clinicians to select the most appropriate treatments based on individual biomarkers. This approval represents a significant advancement in precision oncology, aiming to enhance the speed and accuracy of treatment selection for cancer patients, ultimately improving personalized care.

In February 2025, Renovaro Inc., a US-based biotechnology firm, merged with BioSymetrics Inc. to advance AI-driven biomarker discovery and precision medicine. The merger is intended to improve drug development and enable more personalized treatment strategies, tackling complex diseases through innovative, data-driven methods. BioSymetrics Inc. is a Canada-based phenomics-focused drug discovery company that combines clinical and experimental data using machine learning to promote precision medicine.

Major companies operating in the personalized medicine biomarkers market are AbbVie Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., DH Life Sciences LLC, Myriad Genetics Inc., Guardant Health Inc., Cardiff Oncology Inc., 23andMe Inc., Coriell Life Sciences Inc.

North America was the largest region in the personalized medicine biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized medicine biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized medicine biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized medicine biomarkers market consists of sales of biomarker-based diagnostic kits, reagents, testing platforms, epigenetic biomarkers, companion diagnostics, predictive biomarkers, prognostic biomarkers, and multi-omics biomarkers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Medicine Biomarkers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses personalized medicine biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized medicine biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized medicine biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Biomarker Type: Genomic; Proteomics; Metabolic; Other Biomarker Types
• 2) By Disease Indication: Oncology; Neurology; Diabetes; Autoimmune Diseases; Cardiology; Other Indications
• 3) By Application: Early Detection Or Screening; Diagnosis; Treatment Selection; Monitoring
• 4) By End Use: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Diagnostic Labs; Other End Users
• Subsegments:
• 1) By Genomic: Single Nucleotide Polymorphisms (SNPs); Copy Number Variations (CNVs); Gene Expression Biomarkers; Epigenetic Biomarkers
• 2) By Proteomics: Protein Expression Biomarkers; Post-Translational Modification (PTM) Biomarkers; Protein-Protein Interaction Biomarkers; Enzyme Activity Biomarkers
• 3) By Metabolic: Lipid Biomarkers; Amino Acid Biomarkers; Carbohydrate Biomarkers; Hormone Biomarkers
• 4) By Other Biomarker Types: Inflammatory Biomarkers; Microbiome Biomarkers; Autoantibody Biomarkers; Extracellular Vesicle Biomarkers
• Companies Mentioned: AbbVie Inc.; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG; Merck KGaA; GE Healthcare; Laboratory Corporation of America Holdings (LabCorp); Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.; PerkinElmer Inc.; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DH Life Sciences LLC; Myriad Genetics Inc.; Guardant Health Inc.; Cardiff Oncology Inc.; 23andMe Inc.; Coriell Life Sciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Personalized Medicine Biomarkers Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Personalized Medicine Biomarkers Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Personalized Medicine Biomarkers Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Personalized Medicine Biomarkers Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Precision Treatment Approaches
  • 4.2.2 Increasing Use Of Biomarkers In Oncology Care
  • 4.2.3 Growing Integration Of Companion Diagnostics
  • 4.2.4 Expansion Of Predictive And Prognostic Biomarkers
  • 4.2.5 Higher Focus On Treatment Response Monitoring

5. Personalized Medicine Biomarkers Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Pharmaceutical Companies
• 5.3 Biotechnology Companies
• 5.4 Diagnostic Laboratories
• 5.5 Research Institutions

6. Personalized Medicine Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Personalized Medicine Biomarkers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Personalized Medicine Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Personalized Medicine Biomarkers Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Personalized Medicine Biomarkers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Personalized Medicine Biomarkers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Personalized Medicine Biomarkers Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Personalized Medicine Biomarkers Market Segmentation

• 9.1. Global Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Genomic, Proteomics, Metabolic, Other Biomarker Types
• 9.2. Global Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Other Indications
• 9.3. Global Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Early Detection Or Screening, Diagnosis, Treatment Selection, Monitoring
• 9.4. Global Personalized Medicine Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Diagnostic Labs, Other End Users
• 9.5. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Genomic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single Nucleotide Polymorphisms (SNPs), Copy Number Variations (CNVs), Gene Expression Biomarkers, Epigenetic Biomarkers
• 9.6. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Protein Expression Biomarkers, Post-Translational Modification (PTM) Biomarkers, Protein-Protein Interaction Biomarkers, Enzyme Activity Biomarkers
• 9.7. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Metabolic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lipid Biomarkers, Amino Acid Biomarkers, Carbohydrate Biomarkers, Hormone Biomarkers
• 9.8. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inflammatory Biomarkers, Microbiome Biomarkers, Autoantibody Biomarkers, Extracellular Vesicle Biomarkers

10. Personalized Medicine Biomarkers Market Regional And Country Analysis

• 10.1. Global Personalized Medicine Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Personalized Medicine Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Personalized Medicine Biomarkers Market

• 11.1. Asia-Pacific Personalized Medicine Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Personalized Medicine Biomarkers Market

• 12.1. China Personalized Medicine Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Personalized Medicine Biomarkers Market

• 13.1. India Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Personalized Medicine Biomarkers Market

• 14.1. Japan Personalized Medicine Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Personalized Medicine Biomarkers Market

• 15.1. Australia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Personalized Medicine Biomarkers Market

• 16.1. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Personalized Medicine Biomarkers Market

• 17.1. South Korea Personalized Medicine Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Personalized Medicine Biomarkers Market

• 18.1. Taiwan Personalized Medicine Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Personalized Medicine Biomarkers Market

• 19.1. South East Asia Personalized Medicine Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Personalized Medicine Biomarkers Market

• 20.1. Western Europe Personalized Medicine Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Personalized Medicine Biomarkers Market

• 21.1. UK Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Personalized Medicine Biomarkers Market

• 22.1. Germany Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Personalized Medicine Biomarkers Market

• 23.1. France Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Personalized Medicine Biomarkers Market

• 24.1. Italy Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Personalized Medicine Biomarkers Market

• 25.1. Spain Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Personalized Medicine Biomarkers Market

• 26.1. Eastern Europe Personalized Medicine Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Personalized Medicine Biomarkers Market

• 27.1. Russia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Personalized Medicine Biomarkers Market

• 28.1. North America Personalized Medicine Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Personalized Medicine Biomarkers Market

• 29.1. USA Personalized Medicine Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Personalized Medicine Biomarkers Market

• 30.1. Canada Personalized Medicine Biomarkers Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Personalized Medicine Biomarkers Market

• 31.1. South America Personalized Medicine Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Personalized Medicine Biomarkers Market

• 32.1. Brazil Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Personalized Medicine Biomarkers Market

• 33.1. Middle East Personalized Medicine Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Personalized Medicine Biomarkers Market

• 34.1. Africa Personalized Medicine Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Personalized Medicine Biomarkers Market Regulatory and Investment Landscape

36. Personalized Medicine Biomarkers Market Competitive Landscape And Company Profiles

• 36.1. Personalized Medicine Biomarkers Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Personalized Medicine Biomarkers Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Personalized Medicine Biomarkers Market Company Profiles
  • 36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Personalized Medicine Biomarkers Market Other Major And Innovative Companies

• Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., DH Life Sciences LLC, Myriad Genetics Inc., Guardant Health Inc., Cardiff Oncology Inc., 23andMe Inc.

38. Global Personalized Medicine Biomarkers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Personalized Medicine Biomarkers Market

40. Personalized Medicine Biomarkers Market High Potential Countries, Segments and Strategies

• 40.1 Personalized Medicine Biomarkers Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Personalized Medicine Biomarkers Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Personalized Medicine Biomarkers Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer